Masaki Izumo

Dr. Masaki Izumo

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Cardiovascular Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
MIMasaki Izumo
Masaki Izumo
YAYoshihiro J Akashi
Yoshihiro J Akashi
Takotsubo cardiomyopathy (TTC) is newly-described secondary cardiomyopathy characterized by transient left ventricular (LV) dysfunction, which is increasingly recognized in the field of cardiology. TTC occurs in approximately 2% of the patients with acute coronary syndrome. Its onset is rare; however, its specific features play a crucial role in diagnosing the chest pain in clinical practice. TTC has generally favorable outcome with rapid recovery of LV function; however, an increasing evidence suggests that it should be regarded as a more serious acute cardiac disorder with a variety of complications. Owing to its widespread availability, even in emergency settings, transthoracic echocardiography plays a key role in the diagnostic assessment of TTC and contributes to an increased number of disease detection and incidence reports in contemporary clinical practice. This review focuses on the role of echocardiography in understanding the clinical prognostic implications in patients with TTC.

29 August 2023 in JACC: Asia
Verified
Journal Article
Open access
MSMike Saji
Mike Saji
MYMasanori Yamamoto
Masanori Yamamoto
SKShunsuke Kubo
Shunsuke Kubo
MAMasahiko Asami
Masahiko Asami
YEYusuke Enta
Yusuke Enta
KHKentaro Hayashida
Kentaro Hayashida
Transcatheter edge-to-edge repair (TEER) is a less invasive treatment for patients with mitral regurgitation (MR). Limited safety and efficacy data of TEER with MitraClip, including the fourth-generation (G4) system, in a large cohort, are available. This study aimed to summarize the initial experience of the TEER system in patients with MR from a large registry in Japan. The OCEAN (Optimized CathEter vAlvular iNtervention)-Mitral Registry is an ongoing, prospective, investigator-initiated, multicenter, observational registry for patients with primary and secondary MR undergoing transcatheter mitral valve therapies. A total of 21 centers participated in the registry. Patients undergoing TEER were enrolled, and their characteristics, procedural details, and clinical outcomes were recorded. In total, 2,150 patients including 1,605 patients (75.0%) with secondary MR, were enrolled between April 2018 and June 2021. The median age was 80 years, and 43.7% were women. The median device and fluoroscopy times were 60 and 26 minutes, respectively. Those with the G4 system (618/2,150 [28.7%]) were significantly shorter than those with the second generation (G2) system (1,532/2,150 [71.3%]). Overall, 94.6% met acute procedural success without significant differences between the 2 systems (G2 94.7% vs G4 94.6%; P = 0.961). The OCEAN-Mitral registry has demonstrated the short-term outcomes of TEER systems, including the G4 system, in symptomatic patients with primary and secondary MR. The acute procedural success rate in the G2 system was excellent, and that in the G4 system was expected to improve with the multidisciplinary heart valve team approach. (Japanese Registry study of valvular heart diseases treatment and prognosis; UMIN000023653)

20 September 2009 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
MIMasaki Izumo
Masaki Izumo
PLP. Lancellotti
P. Lancellotti
KSK. Suzuki
K. Suzuki
SKS. Kou
S. Kou
TST. Shimozato
T. Shimozato
FMF. Miyake
F. Miyake
Left ventricular (LV) shape and LV dyssynchrony are two cofactors associated with functional mitral regurgitation (MR) in patients with heart failure. Both can be accurately examined by real-time three-dimensional echocardiography (3DE). We examined the relationship between dynamic MR and exercise-induced changes in LV shape and synchronicity using 3DE. Fifty patients with systolic LV dysfunction underwent 2D and 3D quantitative assessment of LV function, shape, and synchronicity at rest and during symptom-limited exercise test. According to the magnitude of change in MR, patients were divided into EMR group (15 patients, 30%), if the degree of MR increased during test, and NEMR group. During exercise, the changes in LV volumes and ejection fraction were similar in both groups, whereas changes in mitral valvular deformation parameters, in LV sphericity index, and in the extent of LV dyssynchrony were more pronounced in the EMR group. At rest, only the 3D sphericity index could distinguish the two groups. By stepwise multiple regression model, dynamic changes in the systolic dyssynchrony index, sphericity index, and coaptation distance were associated with dynamic MR (r(2) = 0.45, P = 0.012). Dynamic MR during exercise is related to the 3D changes in LV shape and in LV synchronicity.

1 September 2010 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
MIMasaki Izumo
Masaki Izumo
KSKengo Suzuki
Kengo Suzuki
MMMarie Moonen
Marie Moonen
SKSeisyou Kou
Seisyou Kou
TSTakashi Shimozato
Takashi Shimozato
PLPatrizio Lancellotti
Patrizio Lancellotti
Exercise may dramatically change the extent of functional mitral regurgitation (MR) and left ventricular (LV) geometry in patients with chronic heart failure (CHF). We hypothesized that dynamic changes in MR and LV geometry would affect exercise capacity. This study included 30 CHF patients with functional MR who underwent symptom-limited bicycle exercise stress echocardiography and cardiopulmonary exercise testing for quantitative assessment of MR (effective regurgitant orifice; ERO), and pulmonary artery systolic pressure (PASP). LV sphericity index was obtained from real-time three-dimensional echocardiograms. The patients were stratified into exercised-induced MR (EMR; n = 10, an increase in ERO by ≥13 mm2) or non-EMR (NEMR; n = 20, an increase in ERO by <13 mm2) group. At rest, no differences in LV volume and function, ERO, and PASP were found between the two groups. At peak exercise, PASP and sphericity index were significantly greater (all P < 0.01) in the EMR group. The EMR group revealed lower peak oxygen uptake (peak VO2; P = 0.018) and greater minute ventilation/carbon dioxide production slope (VE/VCO2 slope; P = 0.042) than the NEMR group. Peak VO2 negatively correlated with changes in ERO (r = −0.628) and LV sphericity index (r = −0.437); meanwhile, VE/VCO2 slope was well correlated with these changes (r = 0.414 and 0.364, respectively). A multivariate analysis identified that the change in ERO was the strongest predictor of peak VO2 (P = 0.001). Dynamic changes in MR and LV geometry contributed to the limitation of exercise capacity in patients with CHF.

9 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
WKWojciech Kosmala
Wojciech Kosmala
TNTomoko Negishi
Tomoko Negishi
PTPaaladinesh Thavendiranathan
Paaladinesh Thavendiranathan
MPMartin Penicka
Martin Penicka
JBJonathan De Blois
Jonathan De Blois
TMThomas H. Marwick
Thomas H. Marwick
The load dependence of global longitudinal strain (GLS) means that changes in systolic blood pressure (BP) between visits may confound the diagnosis of cancer-treatment-related cardiac dysfunction (CTRCD). We sought to determine whether the estimation of myocardial work, which incorporates SBP, could overcome this limitation. In this case–control study, 44 asymptomatic patients at risk of CTRCD underwent echocardiography at baseline and after oncologic treatment. CTRCD was defined on the basis of the change in the ejection fraction. Those with CTRCD were divided into subsets with and without a follow-up SBP increment >20 mmHg (CTRCD+BP+ and CTRCD+BP−), and matched with patients without CTRCD (CTRCD−BP+ and CTRCD−BP−). The work index (GWI), constructive work (GCW), wasted work (GWW), and work efficiency (GWE) were assessed in addition to the GLS. The largest increases in the GWI and GCW at follow-up were found in CTRCD−BP+ patients. The CTRCD+BP− patients demonstrated significantly larger decreases in GWI and GCW than their CTRCD+BP+ and CTRCD−BP− peers. ROC analysis for the discrimination of LV functional changes in response to increased afterload in the absence of cardiotoxicity revealed higher AUCs for GCW (AUC = 0.97) and GWI (AUC = 0.93) than GLS (AUC = 0.73), GWW (AUC = 0.51), or GWE (AUC = 0.63, all p-values < 0.001). GCW (OR: 1.021; 95% CI: 1.001–1.042; p < 0.04) was the only feature independently associated with CTRCD−BP+. Myocardial work is superior to GLS in the serial assessments in patients receiving cardiotoxic chemotherapy. The impairment of GLS in the presence of an increase in GWI and GCW indicates the impact of elevated afterload on LV performance in the absence of actual myocardial impairment.

1 November 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MOMasaru Obokata
Masaru Obokata
MTMasaaki Takeuchi
Masaaki Takeuchi
KNKazuaki Negishi
Kazuaki Negishi
NONobuyuki Ohte
Nobuyuki Ohte
MIMasaki Izumo
Masaki Izumo
SNSatoshi Nakatani
Satoshi Nakatani